A joint venture has positioned DSM in a fast-growing Chinese food enzyme market.
Royal DSM N.V. (Heerlen, Netherlands) has entered into a joint venture with a Chinese biotech company to provide food enzyme solutions for China.
DSM’s partner in the project is Yixing Qiancheng Bio-Engineering Company Ltd. (Yixing, China), a specialist in food additives since 1993.
According to DSM, China’s food enzymes market is growing at rates far above the global average.
“This joint venture provides DSM with a strong enzyme operating platform in Chinese and Asian markets,” said Lars Asferg, director of enzyme solutions at DSM Food Specialties. “Food is a local business and you need to be present in your customers markets to create innovative solutions to meet the specific local preferences of our customers. The Yixing enzyme plant will expand the DSM global manufacturing networks on the Asian continent.”
Asferg added that the Yixing plant will be upgraded to meet quality and traceability standards as outlined by DSM’s Quality for Life commitment.
DSM is assuming 85% of shares in the joint venture. Yixing will absorb the remaining 15%.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.